Deutsche Bank analyst Falko Friedrichs lowered the firm’s price target on Fresenius Medical to EUR 34 from EUR 46 and keeps a Hold rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FMS:
- Fresenius Medical to sell Boston IVF fertility network, TRIO to IVI RMA
- Fresenius Medical price target raised to EUR 39 from EUR 38 at Barclays
- Fresenius Medical price target lowered to EUR 28 from EUR 32.10 at JPMorgan
- Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter
- FMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
